カテゴリー： QYResearch, 世界

世界の抗腫瘍薬市場 2019年

【英語タイトル】Global Antineoplastic Drugs Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X03660）・商品コード：DATA909X03660
・発行会社（調査会社）：QYResearch
・発行日：2019年11月15日（※2024年版があります。お問い合わせください）
・ページ数：113
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、抗腫瘍薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、化学療法剤、生物学的/免疫療法剤、個別化医療に、用途別には、病院、クリニック、がんリハビリテーションセンター、外来手術センターにセグメント区分し、抗腫瘍薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・抗腫瘍薬の世界市場概要
・抗腫瘍薬の製造コスト構成分析
・抗腫瘍薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・抗腫瘍薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・抗腫瘍薬のセグメント分析（種類別）
（化学療法剤、生物学的/免疫療法剤、個別化医療）
・抗腫瘍薬のセグメント分析（用途別）
（病院、クリニック、がんリハビリテーションセンター、外来手術センター）
・抗腫瘍薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Hoffmann-La Roche、Amgen、Bristol-Myers Squibb、Baxter Healthcare、Boehringer Ingelheim、Aspen Global、Bayer AG、Teva pharmaceutical Industries、Johnson & Johnson、Merc & Co.、Pfize、Accord Healthcare、Genentech、Lundbeck、AbbVie、）
・抗腫瘍薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Antineoplastic Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Antineoplastic Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antineoplastic Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Antineoplastic Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Antineoplastic Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Hoffmann-La Roche
Amgen
Bristol-Myers Squibb
Baxter Healthcare
Boehringer Ingelheim
Aspen Global
Bayer AG
Teva pharmaceutical Industries
Johnson & Johnson
Merc & Co.
Pfize
Accord Healthcare
Genentech
Lundbeck
AbbVie

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Chemotherapeutic Agents
Biological/Immunotherapeutic Agents
Personalized Medicine

Segment by Application
Hospitals
Clinics
Cancer Rehabilitation Centers
Ambulatory Surgical Centers

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Antineoplastic Drugs
1.1 Definition of Antineoplastic Drugs
1.2 Antineoplastic Drugs Segment by Type
1.2.1 Global Antineoplastic Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Chemotherapeutic Agents
1.2.3 Biological/Immunotherapeutic Agents
1.2.4 Personalized Medicine
1.3 Antineoplastic Drugs Segment by Applications
1.3.1 Global Antineoplastic Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cancer Rehabilitation Centers
1.3.5 Ambulatory Surgical Centers
1.4 Global Antineoplastic Drugs Overall Market
1.4.1 Global Antineoplastic Drugs Revenue (2014-2025)
1.4.2 Global Antineoplastic Drugs Production (2014-2025)
1.4.3 North America Antineoplastic Drugs Status and Prospect (2014-2025)
1.4.4 Europe Antineoplastic Drugs Status and Prospect (2014-2025)
1.4.5 China Antineoplastic Drugs Status and Prospect (2014-2025)
1.4.6 Japan Antineoplastic Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Antineoplastic Drugs Status and Prospect (2014-2025)
1.4.8 India Antineoplastic Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Antineoplastic Drugs
2.3 Manufacturing Process Analysis of Antineoplastic Drugs
2.4 Industry Chain Structure of Antineoplastic Drugs

3 Development and Manufacturing Plants Analysis of Antineoplastic Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Antineoplastic Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Antineoplastic Drugs
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Antineoplastic Drugs Production and Capacity Analysis
4.2 Antineoplastic Drugs Revenue Analysis
4.3 Antineoplastic Drugs Price Analysis
4.4 Market Concentration Degree

5 Antineoplastic Drugs Regional Market Analysis
5.1 Antineoplastic Drugs Production by Regions
5.1.1 Global Antineoplastic Drugs Production by Regions
5.1.2 Global Antineoplastic Drugs Revenue by Regions
5.2 Antineoplastic Drugs Consumption by Regions
5.3 North America Antineoplastic Drugs Market Analysis
5.3.1 North America Antineoplastic Drugs Production
5.3.2 North America Antineoplastic Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Antineoplastic Drugs Import and Export
5.4 Europe Antineoplastic Drugs Market Analysis
5.4.1 Europe Antineoplastic Drugs Production
5.4.2 Europe Antineoplastic Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Antineoplastic Drugs Import and Export
5.5 China Antineoplastic Drugs Market Analysis
5.5.1 China Antineoplastic Drugs Production
5.5.2 China Antineoplastic Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Antineoplastic Drugs Import and Export
5.6 Japan Antineoplastic Drugs Market Analysis
5.6.1 Japan Antineoplastic Drugs Production
5.6.2 Japan Antineoplastic Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Antineoplastic Drugs Import and Export
5.7 Southeast Asia Antineoplastic Drugs Market Analysis
5.7.1 Southeast Asia Antineoplastic Drugs Production
5.7.2 Southeast Asia Antineoplastic Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Antineoplastic Drugs Import and Export
5.8 India Antineoplastic Drugs Market Analysis
5.8.1 India Antineoplastic Drugs Production
5.8.2 India Antineoplastic Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Antineoplastic Drugs Import and Export

6 Antineoplastic Drugs Segment Market Analysis (by Type)
6.1 Global Antineoplastic Drugs Production by Type
6.2 Global Antineoplastic Drugs Revenue by Type
6.3 Antineoplastic Drugs Price by Type

7 Antineoplastic Drugs Segment Market Analysis (by Application)
7.1 Global Antineoplastic Drugs Consumption by Application
7.2 Global Antineoplastic Drugs Consumption Market Share by Application (2014-2019)

8 Antineoplastic Drugs Major Manufacturers Analysis
8.1 Hoffmann-La Roche
8.1.1 Hoffmann-La Roche Antineoplastic Drugs Production Sites and Area Served
8.1.2 Hoffmann-La Roche Product Introduction, Application and Specification
8.1.3 Hoffmann-La Roche Antineoplastic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Amgen
8.2.1 Amgen Antineoplastic Drugs Production Sites and Area Served
8.2.2 Amgen Product Introduction, Application and Specification
8.2.3 Amgen Antineoplastic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Bristol-Myers Squibb
8.3.1 Bristol-Myers Squibb Antineoplastic Drugs Production Sites and Area Served
8.3.2 Bristol-Myers Squibb Product Introduction, Application and Specification
8.3.3 Bristol-Myers Squibb Antineoplastic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Baxter Healthcare
8.4.1 Baxter Healthcare Antineoplastic Drugs Production Sites and Area Served
8.4.2 Baxter Healthcare Product Introduction, Application and Specification
8.4.3 Baxter Healthcare Antineoplastic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Boehringer Ingelheim
8.5.1 Boehringer Ingelheim Antineoplastic Drugs Production Sites and Area Served
8.5.2 Boehringer Ingelheim Product Introduction, Application and Specification
8.5.3 Boehringer Ingelheim Antineoplastic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Aspen Global
8.6.1 Aspen Global Antineoplastic Drugs Production Sites and Area Served
8.6.2 Aspen Global Product Introduction, Application and Specification
8.6.3 Aspen Global Antineoplastic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Bayer AG
8.7.1 Bayer AG Antineoplastic Drugs Production Sites and Area Served
8.7.2 Bayer AG Product Introduction, Application and Specification
8.7.3 Bayer AG Antineoplastic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Teva pharmaceutical Industries
8.8.1 Teva pharmaceutical Industries Antineoplastic Drugs Production Sites and Area Served
8.8.2 Teva pharmaceutical Industries Product Introduction, Application and Specification
8.8.3 Teva pharmaceutical Industries Antineoplastic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Johnson & Johnson
8.9.1 Johnson & Johnson Antineoplastic Drugs Production Sites and Area Served
8.9.2 Johnson & Johnson Product Introduction, Application and Specification
8.9.3 Johnson & Johnson Antineoplastic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Merc & Co.
8.10.1 Merc & Co. Antineoplastic Drugs Production Sites and Area Served
8.10.2 Merc & Co. Product Introduction, Application and Specification
8.10.3 Merc & Co. Antineoplastic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Pfize
8.12 Accord Healthcare
8.13 Genentech
8.14 Lundbeck
8.15 AbbVie

9 Development Trend of Analysis of Antineoplastic Drugs Market
9.1 Global Antineoplastic Drugs Market Trend Analysis
9.1.1 Global Antineoplastic Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Antineoplastic Drugs Regional Market Trend
9.2.1 North America Antineoplastic Drugs Forecast 2019-2025
9.2.2 Europe Antineoplastic Drugs Forecast 2019-2025
9.2.3 China Antineoplastic Drugs Forecast 2019-2025
9.2.4 Japan Antineoplastic Drugs Forecast 2019-2025
9.2.5 Southeast Asia Antineoplastic Drugs Forecast 2019-2025
9.2.6 India Antineoplastic Drugs Forecast 2019-2025
9.3 Antineoplastic Drugs Market Trend (Product Type)
9.4 Antineoplastic Drugs Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Antineoplastic Drugs Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Antineoplastic Drugs
Table Global Antineoplastic Drugs Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Antineoplastic Drugs Production Market Share by Types in 2018
Figure Chemotherapeutic Agents Product Picture
Figure Biological/Immunotherapeutic Agents Product Picture
Figure Personalized Medicine Product Picture
Table Global Antineoplastic Drugs Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Antineoplastic Drugs Consumption Market Share by Applications in 2018
Figure Hospitals
Figure Clinics
Figure Cancer Rehabilitation Centers
Figure Ambulatory Surgical Centers
Figure Global Antineoplastic Drugs Revenue (Million USD) (2014-2025)
Figure Global Antineoplastic Drugs Production (K Units) (2014-2025)
Figure North America Antineoplastic Drugs Market Size (Million USD) (2014-2025)
Figure Europe Antineoplastic Drugs Market Size (Million USD) (2014-2025)
Figure China Antineoplastic Drugs Market Size (Million USD) (2014-2025)
Figure Japan Antineoplastic Drugs Market Size (Million USD) (2014-2025)
Figure Southeast Asia Antineoplastic Drugs Market Size (Million USD) (2014-2025)
Figure India Antineoplastic Drugs Market Size (Million USD) (2014-2025)
Table Antineoplastic Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Antineoplastic Drugs in 2018
Figure Manufacturing Process Analysis of Antineoplastic Drugs
Figure Industry Chain Structure of Antineoplastic Drugs
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Antineoplastic Drugs Manufacturing Plants Distribution
Table Antineoplastic Drugs Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Antineoplastic Drugs Capacity (K Units) of Major Manufacturers (2014-2019)
Table Antineoplastic Drugs Production (K Units) of Major Manufacturers (2014-2019)
Table Antineoplastic Drugs Production Market Share of Major Manufacturers (2014-2019)
Figure Antineoplastic Drugs Production Share by Manufacturers in 2018
Table Antineoplastic Drugs Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Antineoplastic Drugs Revenue Market Share of Major Manufacturers (2014-2019)
Figure Antineoplastic Drugs Revenue Share by Manufacturers in 2018
Table Antineoplastic Drugs Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Antineoplastic Drugs Production by Regions 2014-2019 (K Units)
Table Global Antineoplastic Drugs Production Market Share by Regions 2014-2019
Figure Global Antineoplastic Drugs Production Market Share by Regions in 2018
Table Global Antineoplastic Drugs Revenue by Regions 2014-2019 (Million USD)
Table Global Antineoplastic Drugs Revenue Market Share by Regions 2014-2019
Figure Global Antineoplastic Drugs Revenue Market Share by Regions in 2018
Table Global Antineoplastic Drugs Consumption by Regions 2014-2019 (K Units)
Table Global Antineoplastic Drugs Consumption Market Share by Regions 2014-2019
Figure North America Antineoplastic Drugs Production Growth Rate 2014-2019 (K Units)
Figure North America Antineoplastic Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table North America Antineoplastic Drugs Production, Consumption Import and Export (K Units)
Figure Europe Antineoplastic Drugs Production Growth Rate 2014-2019 (K Units)
Figure Europe Antineoplastic Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Antineoplastic Drugs Production, Consumption Import and Export (K Units)
Figure China Antineoplastic Drugs Production Growth Rate 2014-2019 (K Units)
Figure China Antineoplastic Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table China Antineoplastic Drugs Production, Consumption Import and Export (K Units)
Figure Japan Antineoplastic Drugs Production Growth Rate 2014-2019 (K Units)
Figure Japan Antineoplastic Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Antineoplastic Drugs Production, Consumption Import and Export (K Units)
Figure Southeast Asia Antineoplastic Drugs Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Antineoplastic Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Antineoplastic Drugs Production, Consumption Import and Export (K Units)
Figure India Antineoplastic Drugs Production Growth Rate 2014-2019 (K Units)
Figure India Antineoplastic Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table India Antineoplastic Drugs Production, Consumption Import and Export (K Units)
Figure Global Consumption Antineoplastic Drugs Market Share by Application (2014-2019)
Figure Global Value (Consumption) Antineoplastic Drugs Market Share by Application (2014-2019)
Table Hoffmann-La Roche Antineoplastic Drugs Production Sites and Area Served
Table Hoffmann-La Roche Antineoplastic Drugs Product Introduction, Application and Specification
Table Hoffmann-La Roche Antineoplastic Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Hoffmann-La Roche Antineoplastic Drugs Production Growth Rate (2014-2019)
Table Hoffmann-La Roche Antineoplastic Drugs Production Market Share (2014-2019)
Figure Hoffmann-La Roche Antineoplastic Drugs Revenue Market Share (2014-2019)
Table Hoffmann-La Roche Antineoplastic Drugs Main Business and Markets Served
Table Amgen Antineoplastic Drugs Production Sites and Area Served
Table Amgen Antineoplastic Drugs Product Introduction, Application and Specification
Table Amgen Antineoplastic Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Amgen Antineoplastic Drugs Production Growth Rate (2014-2019)
Table Amgen Antineoplastic Drugs Production Market Share (2014-2019)
Figure Amgen Antineoplastic Drugs Revenue Market Share (2014-2019)
Table Amgen Antineoplastic Drugs Main Business and Markets Served
Table Bristol-Myers Squibb Antineoplastic Drugs Production Sites and Area Served
Table Bristol-Myers Squibb Antineoplastic Drugs Product Introduction, Application and Specification
Table Bristol-Myers Squibb Antineoplastic Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Antineoplastic Drugs Production Growth Rate (2014-2019)
Table Bristol-Myers Squibb Antineoplastic Drugs Production Market Share (2014-2019)
Figure Bristol-Myers Squibb Antineoplastic Drugs Revenue Market Share (2014-2019)
Table Bristol-Myers Squibb Antineoplastic Drugs Main Business and Markets Served
Table Baxter Healthcare Antineoplastic Drugs Production Sites and Area Served
Table Baxter Healthcare Antineoplastic Drugs Product Introduction, Application and Specification
Table Baxter Healthcare Antineoplastic Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Baxter Healthcare Antineoplastic Drugs Production Growth Rate (2014-2019)
Table Baxter Healthcare Antineoplastic Drugs Production Market Share (2014-2019)
Figure Baxter Healthcare Antineoplastic Drugs Revenue Market Share (2014-2019)
Table Baxter Healthcare Antineoplastic Drugs Main Business and Markets Served
Table Boehringer Ingelheim Antineoplastic Drugs Production Sites and Area Served
Table Boehringer Ingelheim Antineoplastic Drugs Product Introduction, Application and Specification
Table Boehringer Ingelheim Antineoplastic Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Antineoplastic Drugs Production Growth Rate (2014-2019)
Table Boehringer Ingelheim Antineoplastic Drugs Production Market Share (2014-2019)
Figure Boehringer Ingelheim Antineoplastic Drugs Revenue Market Share (2014-2019)
Table Boehringer Ingelheim Antineoplastic Drugs Main Business and Markets Served
Table Aspen Global Antineoplastic Drugs Production Sites and Area Served
Table Aspen Global Antineoplastic Drugs Product Introduction, Application and Specification
Table Aspen Global Antineoplastic Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Aspen Global Antineoplastic Drugs Production Growth Rate (2014-2019)
Table Aspen Global Antineoplastic Drugs Production Market Share (2014-2019)
Figure Aspen Global Antineoplastic Drugs Revenue Market Share (2014-2019)
Table Aspen Global Antineoplastic Drugs Main Business and Markets Served
Table Bayer AG Antineoplastic Drugs Production Sites and Area Served
Table Bayer AG Antineoplastic Drugs Product Introduction, Application and Specification
Table Bayer AG Antineoplastic Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer AG Antineoplastic Drugs Production Growth Rate (2014-2019)
Table Bayer AG Antineoplastic Drugs Production Market Share (2014-2019)
Figure Bayer AG Antineoplastic Drugs Revenue Market Share (2014-2019)
Table Bayer AG Antineoplastic Drugs Main Business and Markets Served
Table Teva pharmaceutical Industries Antineoplastic Drugs Production Sites and Area Served
Table Teva pharmaceutical Industries Antineoplastic Drugs Product Introduction, Application and Specification
Table Teva pharmaceutical Industries Antineoplastic Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva pharmaceutical Industries Antineoplastic Drugs Production Growth Rate (2014-2019)
Table Teva pharmaceutical Industries Antineoplastic Drugs Production Market Share (2014-2019)
Figure Teva pharmaceutical Industries Antineoplastic Drugs Revenue Market Share (2014-2019)
Table Teva pharmaceutical Industries Antineoplastic Drugs Main Business and Markets Served
Table Johnson & Johnson Antineoplastic Drugs Production Sites and Area Served
Table Johnson & Johnson Antineoplastic Drugs Product Introduction, Application and Specification
Table Johnson & Johnson Antineoplastic Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson Antineoplastic Drugs Production Growth Rate (2014-2019)
Table Johnson & Johnson Antineoplastic Drugs Production Market Share (2014-2019)
Figure Johnson & Johnson Antineoplastic Drugs Revenue Market Share (2014-2019)
Table Johnson & Johnson Antineoplastic Drugs Main Business and Markets Served
Table Merc & Co. Antineoplastic Drugs Production Sites and Area Served
Table Merc & Co. Antineoplastic Drugs Product Introduction, Application and Specification
Table Merc & Co. Antineoplastic Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Merc & Co. Antineoplastic Drugs Production Growth Rate (2014-2019)
Table Merc & Co. Antineoplastic Drugs Production Market Share (2014-2019)
Figure Merc & Co. Antineoplastic Drugs Revenue Market Share (2014-2019)
Table Merc & Co. Antineoplastic Drugs Main Business and Markets Served
Table Pfize Antineoplastic Drugs Production Sites and Area Served
Table Accord Healthcare Antineoplastic Drugs Production Sites and Area Served
Table Genentech Antineoplastic Drugs Production Sites and Area Served
Table Lundbeck Antineoplastic Drugs Production Sites and Area Served
Table AbbVie Antineoplastic Drugs Production Sites and Area Served
Figure Global Antineoplastic Drugs Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Antineoplastic Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Antineoplastic Drugs Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Antineoplastic Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Antineoplastic Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Antineoplastic Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Antineoplastic Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Antineoplastic Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Antineoplastic Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Antineoplastic Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Antineoplastic Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Antineoplastic Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Antineoplastic Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Antineoplastic Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Antineoplastic Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Antineoplastic Drugs by Type (2019-2025)
Table Global Consumption (K Units) of Antineoplastic Drugs by Application (2019-2025)
Table Antineoplastic Drugs Distributors List
Table Antineoplastic Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Hoffmann-La Roche、Amgen、Bristol-Myers Squibb、Baxter Healthcare、Boehringer Ingelheim、Aspen Global、Bayer AG、Teva pharmaceutical Industries、Johnson & Johnson、Merc & Co.、Pfize、Accord Healthcare、Genentech、Lundbeck、AbbVie、

★調査レポート[世界の抗腫瘍薬市場 2019年] (コード：DATA909X03660)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の抗腫瘍薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 膠芽腫治療薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9100019 / GlobalInfoResearch / 2019年10月9日 / 本調査レポートは、膠芽腫治療薬の世界市場について調べ、まとめました。種類別セグメントは、VEGF / VEGFR阻害剤、アルキル化剤、その他の抗腫瘍薬等、用途別セグメントは、病院、がん研究機構、長期介護センター、診断センター等に区分しました。膠芽腫治療薬の世界市場概観、メーカー動向、メーカー別膠芽腫治療薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・膠芽腫治療薬の市場概観 ・膠芽腫治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・膠芽腫治療薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・膠芽腫治療薬の世界市場規模 ・膠芽腫治療薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・膠芽腫治療薬のアメリカ市場規模推移 ・膠芽腫治療薬のカナダ市場規模推移... Scope of the Report: The worldwide market for Glioblastoma Treatment Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Glioblastoma Treatment Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Sigma-Tau Pharmaceuticals F. Hoffmann-La Roche AG Bristol-Myers Squibb...
  • 世界の麻酔薬＆鎮痛薬市場 2019年
    DATA909X03530 / QYResearch / 2019年11月15日 / ※本調査レポートは、麻酔薬＆鎮痛薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、麻酔薬、鎮痛剤に、用途別には、病院、クリニックにセグメント区分し、麻酔薬＆鎮痛薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・麻酔薬＆鎮痛薬の世界市場概要 ・麻酔薬＆鎮痛薬の製造コスト構成分析 ・麻酔薬＆鎮痛薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・麻酔薬＆鎮痛薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・麻酔薬＆鎮痛薬のセグメント分析（種類別） （麻酔薬、鎮痛剤）...The global Anaesthetic Drugs and Pain Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Anaesthetic Drugs and Pain Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anaesthetic Drugs and Pain Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Anaesthetic Drugs and Pain Drugs in North America, Europe, China, Japan, Southeast Asia and...
  • 世界の非ステロイド性抗炎症薬市場 2019年
    DATA909X12088 / QYResearch / 2019年11月20日 / ※本調査レポートは、非ステロイド性抗炎症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、経口、注射に、用途別には、変形性関節症、筋肉痛、腰痛、歯痛、その他にセグメント区分し、非ステロイド性抗炎症薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・非ステロイド性抗炎症薬の世界市場概要 ・非ステロイド性抗炎症薬の製造コスト構成分析 ・非ステロイド性抗炎症薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・非ステロイド性抗炎症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・非ステロイド性抗炎症薬のセグメント分析（種類別） （経口、注射）...The global Nonsteroidal Antiinflammatory Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Nonsteroidal Antiinflammatory Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Nonsteroidal Antiinflammatory Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Nonsteroidal Antiinflammatory Drugs in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

    • ◆H&Iグローバルリサーチのお客様（例）◆